Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 15;29(14):1834-6.
doi: 10.1093/bioinformatics/btt279. Epub 2013 May 15.

DrugMap Central: an on-line query and visualization tool to facilitate drug repositioning studies

Affiliations

DrugMap Central: an on-line query and visualization tool to facilitate drug repositioning studies

Changhe Fu et al. Bioinformatics. .

Abstract

Summary: Systematic studies of drug repositioning require the integration of multi-level drug data, including basic chemical information (such as SMILES), drug targets, target-related signaling pathways, clinical trial information and Food and Drug Administration (FDA)-approval information, to predict new potential indications of existing drugs. Currently available databases, however, lack query support for multi-level drug information and thus are not designed to support drug repositioning studies. DrugMap Central (DMC), an online tool, is developed to help fill the gap. DMC enables the users to integrate, query, visualize, interrogate, and download multi-level data of known drugs or compounds quickly for drug repositioning studies all within one system.

Availability: DMC is accessible at http://r2d2drug.org/DMC.aspx.

Contact: STWong@tmhs.org.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
The search and query methods of the DMC database. (A) The multi-field search. (B) The visualization interface for the multi-level drug data
Fig. 2.
Fig. 2.
The visualization interface for drug-target-pathway information

Similar articles

Cited by

References

    1. Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 2004;3:673–683. - PubMed
    1. Chen X, et al. TTD: therapeutic target database. Nucleic Acids Res. 2002;30:412–415. - PMC - PubMed
    1. Hewett M, et al. PharmGKB: the pharmacogenetics knowledge base. Nucleic Acids Res. 2002;30:163–165. - PMC - PubMed
    1. Iorio F, et al. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl Acad. Sci. USA. 2010;107:14621–14626. - PMC - PubMed
    1. Jin G, et al. A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy. Cancer Res. 2012;72:33–44. - PMC - PubMed

Publication types

Substances